Activation of Immature Dendritic Cells Via Membrane Sialophorin (CD43)
Part of the
Advances in Experimental Medicine and Biology
book series (AEMB, volume 417)
Sialophorin (leukosialin, CD43) is a leukocyte membrane glycoprotein very rich in sialic acid residues and with an extended, mucine-like structure1. Various studies have suggested that CD43 is involved in the regulation of cell-cell interactions as an anti-adhesion molecule and that CD43 can mediate an independent pathway of cytoplasmic signaling and activation in monocytes, T and B lymphocytes2–4. Dendritic cells (DC) are the antigen presenting cells (APC) most efficient in the activation of naive T cells and in the induction of primary T cell-mediated immune responses. In unperturbed tissue, DC exhibit elevated antigen capture capacity but low APC activity (immature DC). Upon activation, DC increase expression of surface MHC and accessory molecules, and become very potent APC. The signals that drive DC maturation are bacterial products and cytokines such as TNF-a and IL-1f3. Maturation of DC, however, is completed only during antigen presentation by interactions between cell surface molecules expressed by T cells and DC (e.g., CD4OL/CD40) and cytokines released by T cells5. Unraveling the factors and the mechanisms involved in DC activation is a very important issue, not only for a better understanding of DC physiology, but also for developing more effective DC-based strategies in the immunotherapy of tumors and infections. In this study, we have investigated the expression and function of CD43 on epidermal Langerhans cells (LC) and in DC generated from peripheral blood monocytes incubated with GMCSF and IL-4 for 6–10 days (Mo-DC).6,7
KeywordsDendritic Cell Antigen Present Cell Dendritic Cell Maturation Immature Dendritic Cell Sialic Acid Residue
Remold-O’Donnel, E., D.M. Kenney, R. Parkman, L. Cairns, B. Savage, and F.S. Rosen. 1984. Characterization of a human lymphocyte sialoglycoprotein that is defective in Wiskott-Aldrich syndrome.. 1. Exp. Med
. 159: 1705–1723.CrossRefGoogle Scholar
Nong, Y.H., E. Remold-O’Donnell, T.W. LeBien, and H.G. Remold. 1989. A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes. J. Exp. Med.
170: 259–267.PubMedCrossRefGoogle Scholar
De Smet, W., H. Walter, and L. Van Hove. 1993. A new CD43 monoclonal antibody induces homotypic aggregation of human leukocytes though a CD1 la/CD18-dependent and -independent mechanism. Immunology
79: 46–54.PubMedGoogle Scholar
Alvarado M., Klassen C., Cerny J., Horejsi V., and Schmidt R.E. 1995. MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation. Eue J. Immunol.
25: 1051–1055.CrossRefGoogle Scholar
Lutz, M.B., G. Girolomoni, and R. Ricciardi-Castagnoli. 1996. The role of cytokines in the functional regulation and differentiation of dendritic cells. Immunohiology
195: 431–455, 1996.CrossRefGoogle Scholar
Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumour necrosis factor-a. J. Exp. Med.
179: 1109–1118.PubMedCrossRefGoogle Scholar
Romani, N., S. Gruner, D. Brang, E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P.O. Fritsch, R.M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood.. 1. Exp. Med
. 180: 83–93.CrossRefGoogle Scholar
Wong, R.C.K., E. Remold-O’Donnell, D. Vercelli, J. Sancho, C. Terhorst, F. Rosen, R. Geha, and T. Chatila. 1990. Signal trasduction via leukocyte antigen CD43 (sialophorin). Feedback regulation by protein kinase C. J. Immunol.
144: 1455–1460.PubMedGoogle Scholar
Manjunath, N., and B. Ardman. 1995. CD43 regulates tyrosine phosphorilation of a 93-kD protein in T lymphocytes. Blood
86: 4194–4198.PubMedGoogle Scholar
Varki, A. 1994. Selectin ligands. Proc. Natl. Acad. Sci. USA
91: 7390–7397.PubMedCrossRefGoogle Scholar
O’Doherty, U., R.M. Steinman, M. Peng, C.U. Cameron, S. Gezelter, I. Kopeloff, W.J. Swiggard, M. Pope, and N. Bhardwaj. 1993. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med.
178: 1067–1078.PubMedCrossRefGoogle Scholar
Zhou, L.-J., and T.F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol.
154: 3821–3835.PubMedGoogle Scholar
Inaba, K., N. Romani, and R.M. Steinman. 1989. An antigen-independent contact mechanism as an early step in T cell-proliferative response to dendritic cells. J. Exp. Med.
170: 527–542.PubMedCrossRefGoogle Scholar
Strunk, D., K. Rappersberger, C. Egger, H. Strobl, E. Kromer, A. Elbe, D. Maurer, and G. Stingl. 1996. Generation of human dendritic cells/Langerhans cells from circulating CD34` hematopoietic progenitor cells. Blood
87: 1292–1302.PubMedGoogle Scholar
Young J.W., and K. Inaba. 1996. Dendritic cells as adjuvants for class I major histocompatibility complexrestricted antitumor immunity. J. Exp. Med.
183: 7–11.PubMedCrossRefGoogle Scholar
Hsu, F.J., C. Benike, F. Fagnoni, T.M. Liles, D. Czerwinski, B. Taidi, E.G. Engleman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med.
2: 52–58.PubMedCrossRefGoogle Scholar
© Springer Science+Business Media New York 1997